Promoter methylation of DAPK1, FHIT, MGMT, and CDKN2A genes in cervical carcinoma

International Journal of Clinical Oncology

Volumn 19, Issue 1, 2014, Pages 127-132

  Banzai, Chiaki ^a   Nishino, Koji ^a   Quan, Jinhua ^a   Yoshihara, Kosuke ^a   Sekine, Masayuki ^a   Yahata, Tetsuro ^a   Tanaka, Kenichi ^a  

^a NIIGATA UNIVERSITY GRADUATE SCHOOL OF MEDICAL AND DENTAL SCIENCES   (Japan)

Author keywords

Cervical cancer; DAPK1; Methylation

Indexed keywords

ACID ANHYDRIDE HYDROLASES; ADULT; CARCINOMA IN SITU; CARCINOMA, SQUAMOUS CELL; CYCLIN-DEPENDENT KINASE INHIBITOR P16; DEATH-ASSOCIATED PROTEIN KINASES; DNA METHYLATION; DNA MODIFICATION METHYLASES; DNA REPAIR ENZYMES; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MIDDLE AGED; NEOPLASM PROTEINS; PROMOTER REGIONS, GENETIC; TUMOR SUPPRESSOR PROTEINS; UTERINE CERVICAL NEOPLASMS;

EID: 84894584345     PISSN: 13419625     EISSN: 14377772     Source Type: Journal    
DOI: 10.1007/s10147-013-0530-0     Document Type: Article

References (30)

1. Center for Cancer Control and Information Services, National Cancer Center, Japan. http://ganjohojp/professional/statistics/statisticshtml
2. Walboomers JM, Jacobs MV, Manos MM, et al. (1999) Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 189:12-19
3. Schiffman MH, Castle P (2003) Epidemiologic studies of a necessary causal risk factor: human papillomavirus infection and cervical neoplasia. J Natl Cancer Inst 95:E2
4. Bosch FX, Manos MM, Munoz N, et al. (1995) Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. International biological study on cervical cancer (IBSCC) study group. J Natl Cancer Inst 87:796-802
5. Waggoner SE (2003) Cervical cancer. Lancet 361:2217-2225
6. Holowaty P, Miller AB, Rohan T, et al. (1999) Natural history of dysplasia of the uterine cervix. J Natl Cancer Inst 91:252-258
7. Jones PA, Baylin SB (2002) The fundamental role of epigenetic events in cancer. Nat Rev Genet 3:415-428
8. Baldwin RL, Nemet E, Tran H, et al. (2004) BRCA1 promoter region hypermethylation in ovarian carcinoma: a population-based study. Cancer Res 60:5329-5333
9. Salvesen HB, Macdonald N, Ryan A, et al. (2001) PTEN methylation is associated with advanced stage and microsatellite instability in endometrial carcinoma. Int J Cancer 91:22-26
10. Zyaman M, Saka A, Millar A, et al. (2002) Methylation of adenomatous polyposis coli in endometrial cancer occurs more frequently in tumors with microsatellite instability phenotype. Cancer Res 62:3663-3666
11. Yang HJ, Lin VWS, Wang Y, et al. (2004) Detection of hypermethylated genes in tumor and plasma of cervical cancer patients. Gynecol Oncol 93:435-440
12. Dimitrios I, Pangona O, Ioannis M, et al. (2009) Correlation of promoter hypermethylation in hTERT, DAPK and MGMT genes with cervical oncogenesis progression. Oncol Rep 22:199-204
13. Zhao XL, Meng ZY, Qiao YH, et al. (2008) Promoter methylation of DAPK gene in cervical carcinoma. Chin J Cancer 27(9):212-215
14. Dong SM, Kim HS, Rha SH, et al. (2001) Promoter methylation of multiple genes in carcinoma of the uterine cervix. Clin Cancer Res 7:1982-1986
15. Virmani AK, Muller C, Rathi A, et al. (2001) Aberrant methylation during cervical carcinogenesis. Clin Cancer Res 7:584-589
16. Narayan G, Arias-Pulido H, Koul S, et al. (2003) Frequent promoter methylation of CDH1, DAPK, RARB, and HIC1 genes in carcinoma of cervix uteri: its relationship to clinical outcome. Mol Cancer 2:24
17. Jeong DH, Youm MY, Kin YN, et al. (2006) Promoter methylation of p16, DAPK, CDH1, and TIMP-3 genes in cervical cancer: correlation with clinicopathologic characteristics. Int J Gynecol Cancer 16:1234-1240
18. Widschwendter A, Gattringer C, Ivarsson L, et al. (2004) Analysis of aberrant DNA methylation and human papillomavirus DNA in cervicovaginal specimens to detect invasive cervical cancer and its precursors. Clin Cancer Res 10:3396-3400
19. Lea JS, Coleman R, Kurien A, et al. (2004) Aberrant p16 methylation is a biomarker for tobacco exposure in cervical squamous cell carcinogenesis. Am J Obstet Gynecol 190:674-679
20. Wong YF, Chung TK, Cheung TH, et al. (1999) Methylation of p16INK4A in primary gynecologic malignancy. Cancer Lett 136:231-235
21. Widschwendter A, Muller HM, Fiegl H, et al. (2004) DNA methylation in serum and tumors of cervical cancer patients. Clin Cancer Res 10:565-571
22. Ivanova T, Vinokurova S, Petrenko A, et al. (2004) Frequent methylation of 5′ flanking region of TIMP-2 gene in cervical cancer. Int J Cancer 108:882-886
23. Widschwendter A, Ivarsson L, Blassnig A, et al. (2004) CDH1 and CDH13 methylation in serum is an independent prognostic marker in cervical cancer patients. Int J Cancer 109:163-166
24. Michie AM, McCaig AM, Nakagawa R, et al. (2010) Death-associated protein kinase (DAPK) and signal transduction: regulation in cancer. FEBS J 277:74-80
25. Ki KD, Lee SK, Tong SY, et al. (2008) Role of 5′-CpG island hypermethylation of the FHIT gene in cervical carcinoma. J Gynecol Oncol 19(2):117-122
26. Baylin SB, Herman JG, Graff JR, et al. (1998) Alterations in DNA methylation: a fundamental aspect of neoplasia. Adv Cancer Res 72:141-196
27. Jones PA, Laird PW (1999) Cancer epigenetic comes of age. Nat Genet 21:163-167
28. Lea JS, Coleman R, Kurien A, et al. (2004) Aberrant p16 methylation is a biomarker for tobacco exposure in cervical squamous cell carcinogenesis. Am J Obstet Gynecol 190:674-679
29. Onuki M, et al. (2009) Human papillomavirus infections among Japanese women: age-related prevalence and type-specific risk for cervical cancer. Cancer Sci 100(7):1312-1316
30. Lin Z, Gao M, Zhang X, et al. (2005) The hypermethylation and protein expression of p16 INK4A and DNA repair gene O6-methylguanine-DNA methyltransferase in various uterine cervical lesions. J Cancer Res Clin Oncol 131(6):364-370